DOCSLIB.ORG

Surgical Management of Male Infertility

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Surgical Management of Male Infertility 10/2/2020 Surgical Management of Male Infertility KATHLEEN HWANG, MD ASSOCIATE PROFESSOR OF UROLOGY DIRECTOR OF MALE REPRODUCTIVE HEALTH UNIVERSITY OF PITTSBURGH MEDICAL SCHOOL MAY 22, 2020 1 1 Disclosures None 2 2 Reproductive health Fertility Preservation Adult Male Reproductive Urologist Referrals from Pediatric Urologists Pediatric Endocrinology Pediatric and Adolescent Gynecologist 3 3 1 10/2/2020 Partnership with REI We work together in the same space as the REI clinic New Endeavor Started in 2019 Couples are seen together ARTs Cryopreserved Sperm Intrauterine Insemination (IUI) In vitro Fertilization with Intracytoplasmic sperm injection (IVF/ICSI) 4 4 Fertility Preservation Strategies for the Male Reproductive System 5 5 Preservation Strategies Minimizing Testicular Damage Sperm Cryopreservation Masturbation Penile Vibratory Stimulation (PVS) Electroejaculation (EEJ) Post-Ejaculate Urinalysis Testicular Sperm Extraction Aspiration Extraction (open biopsy) Office vs. Operating Room Random vs. Microdissection 6 6 2 10/2/2020 Relevant Patient Populations: Gonadotoxic Cancer Patients: Adult vs. Pediatric Chemotherapy Radiation Surgical Transgender Anabolic steroid usage Post-mortem Medical disease Klinefelter’s Autoimmune disease 7 7 Martinez et al. Fertility and Sterility 2017 September 8 Alternate Methods of Inducing Ejaculation Various scenarios where masturbation is not possible Penile Vibratory Stimulation Electroejaculation Diabetic neuropathy Multiple sclerosis Spinal Cord Injury Post-RPLND Post-rectal cancer surgery 9 9 3 10/2/2020 Diagnostic and Therapeutic Testis Biopsy Techniques Open biopsy Fine needle aspiration Microscopic testicular sperm extraction (TESE) 10 Sperm Collection Masturbation Penile Vibratory Stimulation Advantages Advantages Simple Non-invasive Inexpensive Rare complications Disadv antages Disadv antages Requires sperm bank Specialized equipment and training Difficulties due to age, culture, physical limitations Requires intact reflex arc 11 11 Sperm Collection Electroejaculation Testicular sperm extraction Advantages Advantages High Retrieval Rates Modest retrieval rates Disadvantages Disadvantages Invasive Invasive Anesthesia Anesthesia Specialized equipment and training Specialized training for micro-TESE Minimal data in teenagers Usually small numbers of sperm found Minimal data in pre-therapy population Rare complications Rare complications 12 12 4 10/2/2020 Rates of Sperm Cryopreservation National vs. Regional Implementation of a nurse counseling session that included fertility preservation at Hospital System1 2.9 times likely to bank sperm 6.4% men vs. 17.6% men utilized cryopreservation before vs. after implementation of education session 1Rotker et al. Efficacy of Standardized Nursing Fertility Counseling on Sperm Banking 13 Rates in Cancer Patients. Urology 2017 13 Utilization of Cryopreserved Sperm Cohort of 272 men with cancer Live birth rate of 62.1% with ICSI Cohort of 898 men with cancer in the Netherlands2 Live Birth rates IUI: 13% IVF: 29% ICSI: 33% 1Garcia et al. Assisted reproductive outcomes of male cancer survivors. J Cancer Surviv 2015 14 2Muller et al. Semen cryopreservation and usage rate for ART in 898 men with cancer. Reprod Biomed. 2016 14 Preserving Fertility in Patients: • Importance the Discussion at the Earliest Possible Time • Sperm cryopreservation BEFORE any Gonadotoxic Therapy • Referral to Specialist if Patient is Interested 15 5 10/2/2020 Fertility Preservation Prior to initiation of Hormonal Replacement Therapy Need to ask the question Perhaps 10% or so Estrogen suppresses pituitary output of LH and FSH Cessation of intratesticular testosterone synthesis Disruption of spermatogenesis Prior to orchiectomy Need to ask the question 16 16 Fertility Preservation Not easy or desirable to ejaculate May be sexually immature Counts may be lower Prior to HRT Certainly on hormonal therapy Financial considerations 17 17 Sperm Cryopreservation: Covered or not ? Variable depending on State Viral Testing Semen sample processing Cryo Storage fees (monthly vs. annually) 18 18 6 10/2/2020 Fertility Options for Transgender Individuals 19 19 Data on Fertility Preservation in Transgender Population 20 Adeleye et al, Urology 2018 20 Fertility Preservation Counseling • 72 subjects with 141 orchiectomy specimens • Histological Assessment for level of spermatogenesis • 81% had germ cells present • 40% had elongated spermatids • Size Matters • 85% of specimens > or = to 25 mL in testicular size had mature spermatids • Testicular Sperm Extraction Options • Even ex vivo at time of orchiectomy Jiang et al, Urology 2019 21 7 10/2/2020 Retrospective assessment of post thaw quality of frozen vials Total 260 TransWomen 12 had prior hormonal therapy All stopped at least 3 months prior to semen cryopreservation 22 GRS Male to Female Fertility Issues 23 23 GRS: Male to Female Fertility Issues Options for Sperm Cryopreservation Ejaculation prior to starting endocrine therapy Ejaculation after starting endocrine therapy Sperm retrieval at time of orchiectomy New WPATH guidelines Sept 2011 “All Health Care Professionals should discuss reproductive options prior to initiating MEDICAL and/or SURGICAL treatment” 24 24 8 10/2/2020 Fertility Preservation: M to F 25 25 Fertility Preservation: M to F 26 26 Fertility Preservation: M to F 27 27 9 10/2/2020 PATIENT KNOWLEDGE AND INTEREST IN CRYOPRESERVATION OF SPERM IN PATIENTS PRESENTING FOR MALE TO FEMALE GENDER AFFIRMING SURGERY Ruth Blum MD1, Rafaela Mangino PA2, James Rosoff MD2, Stanton Honig MD1,2 Division of Urology, University of Connecticut, Farmington, CT 1 Department of Urology, Yale University, New Haven, CT 2 28 RESULTS Patient Patients Interested in PatiCharacteristicsents Not interested in P-Value Cryopreservation (N=9) Cryopres(N=79)ervation (N=70) Average ageAverage(years) age2 6(years) (16-39) 3436 (1(168-68-68)) 0.04 Duration of dressing in 8.4 (1.5-17) 9.8 (1-52) 0.61 female gendeDurationr (years) of dressing in Duration of hormone 9.8 (1-52) female gender6.9 (years)(1-17) 5.4 (1-27) 0.35 therapy (years) Patients witDurationh prior of hormone 0 (0%) 5.67 (10 (1.9%-27)) 0.25 childretherapyn (years) Patients with prior children 9.6% (N=7) Knowledge of 100% (N= 79) cryopreservation Interest in 11.4% (N=9) cryopreservation 29 29 Interest in Fertility Preservation (M to F)? Ejaculate prior to starting EST Unable to ejaculate or already on EST Sperm present and cryopreserve Check ejaculate on EST Sperm present and No sperm cryopreserve Stop EST and obtain ejaculate No sperm present, proceed with Sperm present and cryopreserve TESE prior to or at time of GAS/orchiectomy 30 30 10 10/2/2020 Feminizing effect on Testis Histology Schneider et al J Sex Med 2015:12:2190-2200. 108 pts from multiple GAS centers 3 groups Discontinued estrogen 6 weeks prior to surgery Discontinued estrogen 2 weeks prior to surgery No estrogen discontinuation 31 31 Feminizing effect on Testis Histology Results Stopped estrogen Higher T levels, higher intra-testicular Testsosterone levels Higher gonadotropins EXTREMELY variable histology in all the groups (even in those that did NOT stop estrogen) Suppression of gonadotropins did NOT necessarily reflect the differentiation status of germ cells (spermatogenesis) Could reflect compliance of patients taking meds. 32 32 Orchiectomy Histology Data in GAS (AUA 2018) Lao and Honig (n=21) Correlation of histology to sperm retrieval data Spermatogenesis in 26% pts (based on histology) 50% sperm retrieval rate (in those interested) Mixed population of estrogen/non estrogen 33 33 11 10/2/2020 The Future 34 34 What About Prepubertal Males? No effective means of fertility preservation currently available Numerous investigational approaches being studied Cryopreservation of testicular tissue Completed under research study and experimental Autotransplantation Xenotransplantation In vitro sperm maturation 35 35 Research: Transgender FP Protocol Title: Testicular tissue cryopreservation in the setting of feminizing therapy Specific Aims: Testicular tissue freezing prior to feminizing therapy study is open to transgender female patients who have not reached spermarche. The study aims to determine the acceptability and provide a new fertility preservation option (testicular tissue freezing) for young transgender patients and provide research tissue to enable researchers to responsibly develop next generation technologies that may allow patients to use their tissues for reproductive purposes in the future. Research will: 1) Optimize tissue processing and cryopreservation methods 2) Confirm the presence and quantity of germ cells (sperm precursors) in patient tissues (to be reported back to patients) 3) Develop next generation cell- and tissue-based therapies to preserve fertility and treat infertility. 36 36 12 10/2/2020 Research: Transgender FP Protocol Title: Ovarian tissue cryopreservation in the setting of masculinizing therapy The study aims to determine the acceptability and provide a new fertility preservation option (ovarian tissue freezing) for young transgender patients and provide research tissue to enable researchers to responsibly develop next generation technologies that may allow patients to use their tissues for reproductive purposes in the future. Ovarian tissue will be used for research to address various research aims, including, but not limited to: 1) To optimize techniques for cryopreservation of ovarian tissues, including determining efficacy of cryopreservation techniques 2) To investigate factors affecting ovarian tissue and follicles, such as previous treatment with leuprolide acetate, or hormone therapy 37 37 38 Have the conversation about Fertility Preservation Options EARLY Conclusions Even if your local institution does not have a Fertility Preservation Program 39 39 13 10/2/2020 Thank You 40 40 14.
Load more

Recommended publications
  • Novel Ways of Assessing Puberty
    NOVEL WAYS OF ASSESSING PUBERTY Findings from the Adolescent Rural Cohort Study of Hormones, Health, Education, Environments and Relationships Ben W.R. Balzer B.Med.Sc., M.B., B.S. (Syd.) A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy Discipline of Child and Adolescent Health, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney Primary Supervisor: Professor Katharine S. Steinbeck Medical Foundation Chair in Adolescent Medicine, The University of Sydney 2019 STATEMENT OF AUTHENTICATION This thesis is submitted to the University of Sydney in fulfilment of the requirement is for the Degree of Doctor of Philosophy. The work presented in this thesis is, to the best of my knowledge and belief, original except as acknowledged in the text. I hereby declare that I have not submitted this material, either in full or in part, for a degree at this or any other institution. Signature: Ben W.R. Balzer Date: 3 June 2019 i ACKNOWLEDGEMENTS I would like to thank Professor Kate Steinbeck for her role as my primary supervisor. I have worked with Kate since 2010, when I first joined the Academic Department of Adolescent Medicine as a Summer Research Scholar. Her expertise, supervision and support have been inspiring and have brought this thesis to fruition. Thank you also to my associate supervisors, Professor David Handelsman and Associate Professor Catherine Hawke, whose time and input have benefitted me greatly and been vital to this project’s success. I wish to acknowledge the National Health and Medical Research Council Project Grant awarded to Professor SteinbecK and I am grateful for personal support from the University of Sydney Faculty of Medicine through the Postgraduate Research Support Scheme and the Dean’s Scholarship Fund Conference Grant.
    [Show full text]
  • Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due To
    Original Study Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments K. Oktay MD 1,2,*, G. Bedoschi MD 1,2 1 Innovation Institute for Fertility Preservation and IVF, New York, NY 2 Laboratory of Molecular Reproduction and Fertility Preservation, Obstetrics and Gynecology, New York Medical College, Valhalla, NY abstract Objective: To preliminarily study the feasibility of oocyte cryopreservation in postpubertal girls aged between 13 and 15 years who were at risk for premature ovarian failure due to the accelerated follicle loss associated with Turner syndrome or cancer treatments. Design: Retrospective cohort and review of literature. Setting: Academic fertility preservation unit. Participants: Three girls diagnosed with Turner syndrome, 1 girl diagnosed with germ-cell tumor. and 1 girl diagnosed with lymphoblastic leukemia. Interventions: Assessment of ovarian reserve, ovarian stimulation, oocyte retrieval, in vitro maturation, and mature oocyte cryopreservation. Main Outcome Measure: Response to ovarian stimulation, number of mature oocytes cryopreserved and complications, if any. Results: Mean anti-mullerian€ hormone, baseline follical stimulating hormone, estradiol, and antral follicle counts were 1.30 Æ 0.39, 6.08 Æ 2.63, 41.39 Æ 24.68, 8.0 Æ 3.2; respectively. In Turner girls the ovarian reserve assessment indicated already diminished ovarian reserve. Ovarian stimulation and oocyte cryopreservation was successfully performed in all female children referred for fertility preser- vation. A range of 4-11 mature oocytes (mean 8.1 Æ 3.4) was cryopreserved without any complications. All girls tolerated the procedure well.
    [Show full text]
  • Social Freezing: Pressing Pause on Fertility
    International Journal of Environmental Research and Public Health Review Social Freezing: Pressing Pause on Fertility Valentin Nicolae Varlas 1,2 , Roxana Georgiana Bors 1,2, Dragos Albu 1,2, Ovidiu Nicolae Penes 3,*, Bogdana Adriana Nasui 4,* , Claudia Mehedintu 5 and Anca Lucia Pop 6 1 Department of Obstetrics and Gynaecology, Filantropia Clinical Hospital, 011171 Bucharest, Romania; [email protected] (V.N.V.); [email protected] (R.G.B.); [email protected] (D.A.) 2 Department of Obstetrics and Gynaecology, “Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu St., 020021 Bucharest, Romania 3 Department of Intensive Care, University Clinical Hospital, “Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu St., 020021 Bucharest, Romania 4 Department of Community Health, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania 5 Department of Obstetrics and Gynaecology, Nicolae Malaxa Clinical Hospital, 020346 Bucharest, Romania; [email protected] 6 Department of Clinical Laboratory, Food Safety, “Carol Davila” University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; [email protected] * Correspondence: [email protected] (O.N.P.); [email protected] (B.A.N.) Abstract: Increasing numbers of women are undergoing oocyte or tissue cryopreservation for medical or social reasons to increase their chances of having genetic children. Social egg freezing (SEF) allows women to preserve their fertility in anticipation of age-related fertility decline and ineffective fertility treatments at older ages. The purpose of this study was to summarize recent findings focusing on the challenges of elective egg freezing.
    [Show full text]
  • Clinical Potential and Putative Risks of Fertility Preservation in Children Utilizing Gonadal Tissue Or Germline Stem Cells
    0031-3998/06/5904-0040R PEDIATRIC RESEARCH Vol. 59, No. 4, Pt 2, 2006 Copyright © 2006 International Pediatric Research Foundation, Inc. Printed in U.S.A. Clinical Potential and Putative Risks of Fertility Preservation in Children Utilizing Gonadal Tissue or Germline Stem Cells KIRSI JAHNUKAINEN, JENS EHMCKE, OLLE SO¨ DER, AND STEFAN SCHLATT Department of Cell Biology and Physiology [K.J., J.E., S.S.], Center for Research in Reproductive Physiology, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15261; Department of Pediatrics [K.J], University of Turku, FIN-20520 Turku, Finland; Department of Woman and Child Health [K.J., O.S], Pediatric Endocrinology Unit, Karolinska Institute and University Hospital, SE-171 76 Stockholm, Sweden ABSTRACT: Rapid progress in the development of novel experi- a finite stock of oocytes at birth. Only a few oocytes will be mental strategies to generate fertile gametes from cryo-preserved released during ovulation during reproductive life. The ma- ovarian and testicular tissue motivates oncologists to investigate jority will be lost due to atretic degeneration, and replenish- ways in which gonadal tissue might be preserved. Childhood cancer ment of the oocyte pool from germline stem cells does not patients remain the major pediatric group which can benefit from occur (3–5) (Fig. 1). However, recent reports have challenged these techniques. Other potential candidates include patients with this concept. It has been shown that primordial germ cells in systemic diseases, which require gonadotoxic chemotherapy, patients undergoing gonadectomy, patients with Turner or Kleinefelter’s syn- culture dishes are capable of forming oogonia and follicle-like drome, and boys with cryptorchid testes.
    [Show full text]
  • A Review of the Incidence and Survival of Childhood and Adolescent Cancer and the Effects of Treatment on Future Fertility and Endocrine Development
    REVIEW A review of the incidence and survival of childhood and adolescent cancer and the effects of treatment on future fertility and endocrine development M H Botha, MMed (O&G), PhD Unit for Gynaecological Oncology, Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Academic Hospital, Tygerberg, Western Cape T F Kruger, MB ChB, MPharmMed (Clin Pharm), MMed (O&G), FCOG (SA), FRCOG (Lond), MD Unit for Reproductive Biology, Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Academic Hospital Cancer is not uncommon in children. The reproductive system is an important site for late effects of cancer treatment, and normal pubertal development depends on an undamaged hypothalamic-pituitary-gonadal axis. Fertility compromise can occur due to chemotherapy, radiotherapy to the hypothalamic-pituitary-gonadal axis, or surgery. Cryopreservation techniques of germ cells are improving and may offer hope for fertility preservation. S Afr J OG 2012;18(2):48-53. Cancer is not an uncommon diagnosis in children. The incidence Older children and young adults have historically not been of childhood cancer (generally referring to children up to the age of studied to the same extent as young children with regard to 15) is 110 - 130 per million children per annum.1 It is estimated that cancer incidence. The age range for adolescence for the purpose the cumulative risk of a child being diagnosed with cancer is slightly of scientific reporting has been set at 15 - 19 years.6 More recently higher in boys (1:444) compared with girls (1:594).2 In South Africa the concept of ‘young adult oncology’ has referred to a larger group accurate figures for childhood cancer are not available.
    [Show full text]
  • Approaches and Technologies in Male Fertility Preservation
    International Journal of Molecular Sciences Review Approaches and Technologies in Male Fertility Preservation Mahmoud Huleihel 1,2,* and Eitan Lunenfeld 2,3,4 1 The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel 2 The Center of Advanced Research and Education in Reproduction (CARER), Ben-Gurion University of the Negev, Beer Sheva 84105, Israel; lunenfl[email protected] 3 Department of OB/GYN, Soroka Medical Center, Beer Sheva 8410501, Israel 4 Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel * Correspondence: [email protected]; Tel.: +972-86479959 Received: 28 May 2020; Accepted: 29 July 2020; Published: 31 July 2020 Abstract: Male fertility preservation is required when treatment with an aggressive chemo-/-radiotherapy, which may lead to irreversible sterility. Due to new and efficient protocols of cancer treatments, surviving rates are more than 80%. Thus, these patients are looking forward to family life and fathering their own biological children after treatments. Whereas adult men can cryopreserve their sperm for future use in assistance reproductive technologies (ART), this is not an option in prepubertal boys who cannot produce sperm at this age. In this review, we summarize the different technologies for male fertility preservation with emphasize on prepubertal, which have already been examined and/or demonstrated in vivo and/or in vitro using animal models and, in some cases, using human tissues. We discuss the limitation of these technologies for use in human fertility preservation. This update review can assist physicians and patients who are scheduled for aggressive chemo-/radiotherapy, specifically prepubertal males and their parents who need to know about the risks of the treatment on their future fertility and the possible present option of fertility preservation.
    [Show full text]
  • Preservation of Fertility in Patients with Cancer (Review)
    ONCOLOGY REPORTS 41: 2607-2614, 2019 Preservation of fertility in patients with cancer (Review) SOFÍA DEL-POZO-LÉRIDA1, CRISTINA SALVADOR2, FINA MARTÍNEZ-SOLER3, AVELINA TORTOSA3, MANUEL PERUCHO4,5 and PEPITA GIMÉNEZ-BONAFÉ1 1Department of Physiological Sciences, Physiology Unit, Faculty of Medicine and Health Sciences, Bellvitge Campus, Universitat de Barcelona, IDIBELL, L'Hospitalet del Llobregat, 08907 Barcelona; 2Department of Gynecology, Gynecological Endocrinology and Reproduction Unit, Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat, 08950 Barcelona; 3Department of Basic Nursing, Faculty of Medicine and Health Sciences, Universitat de Barcelona, IDIBELL, L' Hospital et del Llobregat, 08907 Barcelona, Spain; 4Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, CA 92037, USA; 5Program of Predictive and Personalized Medicine of Cancer (PMPPC), of the Research Institute Germans Trias i Pujol (IGTP), Badalona, 08916 Barcelona, Spain Received January 18, 2019; Accepted March 6, 2019 DOI: 10.3892/or.2019.7063 Abstract. Survival rates in oncological patients have been techniques evaluated. Emerging techniques are promising, steadily increasing in recent years due to the greater effec- such as the cryopreservation in orthotopic models of ovarian tiveness of novel oncological treatments, such as radio- and or testicle tissues, artificial ovaries, or in vitro culture prior chemotherapy. However, these treatments impair the reproduc- to the autotransplantation of cryopreserved tissues. However, tive ability of patients, and may cause premature ovarian failure oocyte vitrification for female patients and sperm banking for in females and azoospermia in males. Fertility preservation male patients are considered the first line fertility preserva- in both female and male oncological patients is nowadays tion option at the present time for cancer patients undergoing possible and should be integrated as part of the oncological treatment.
    [Show full text]
  • A Guide for Teaching About Adolescent Sexuality and Reproductive Health
    CHRISTIAN FAMILY LIFE EDUCATION: A Guide for Teaching about Adolescent Sexuality and Reproductive Health Written by Shirley Miller for Margaret Sanger Center International © 2001 ~ This guide was written especially for Christians and others who value the importance of talking comfortably and effectively with young people and adults about issues related to healthy sexuality and reproductive health. It provides state of the art information on a variety of topics related to human sexuality, gender, adolescents, growth and development, parenting, domestic violence, STIs, HIV/AIDS, sexual abuse, substance abuse, conflict resolution, goal setting and other important life issues. ~ Margaret Sanger Center International, Copyright 2001 2 CONTENTS Page PREFACE..............................................................................................9 INTRODUCTION: Why Christian Family Life Education? .............10 Important Issues Concerning Adolescents.....................................13 PART ONE: CHRISTIAN FAMILY LIFE EDUCATION About This Guide..................................................................................16 Objectives of the Christian Family Life Education Programme............18 Characteristics of an Effective Christian Family Life Educator ...........20 Providing Support for Parents ..............................................................22 Communicating with Young People about Sex....................................23 Clarifying Values ..................................................................................25
    [Show full text]
  • Kristen Cain, MD, FACOG Reproductive Medicine Institute Sanford Health, Fargo, ND
    Kristen Cain, MD, FACOG Reproductive Medicine Institute Sanford Health, Fargo, ND s Nothing to Disclose s Reproductive age patients value their fertility Survival of childhood and adult cancers is increasing Treatment and preservation options continue to evolve Failure to discuss fertility issues with young cancer patients can have lasting negative consequences Duffy C et al, Cancer J 2009, 15;27-33. Simon B et al CA Cancer J Clin 2005 55;211-228 Annually more than 130,000 cancer patients are diagnosed in their reproductive years (up to 45) 1 More than 11,000 breast cancer patients are diagnosed under the age of 40 each year 2 21% of gynecologic cancer patients are diagnosed under the age of 45 3 12,000 children (0-19) are diagnosed with cancer each year 4 5-7% invasive breast cancer cases occur in women under the age of 40 (www.seer.cancer.gov.2008 ) 1 American Cancer Society & U.S. Census Bureau 2 Young Survival Coalition 3 Liou WS, Yap S, et al., Fertility and Sterility, 2005. 4 Goodwin T, Ooosterhuis BE, et al., Pediatric Blood Cancer,s 2007. Increasing Cancer Survival Rates Increased Emphasis on Quality of Life + Many Successful Fertility Preservation & Post-treatment Parenthood Options = Patients Need Information About Fertility Risks & Options s Cancer Survivorship Rates are High 77% percent of patients under 45 survive at least five years 1 US Trend: Delayed Childbearing Average age for first child is 25.2 – an all time high 2 More patients have not had children when diagnosed Nearly ¼ of first-time live births occur to women over the age of 30 1 SEER Cancer Statistics Review, 1997-2004.
    [Show full text]
  • Onset of the Release of Spermatozoa (Spermarche) in Chinese Male Youth
    AMERICAN JOURNAL OF HUMAN BIOLOGY 12:577–587 (2000) Onset of the Release of Spermatozoa (Spermarche) in Chinese Male Youth CHENG-YE JI1* AND SEIJI OHSAWA2 1Department of Health Care Epidemiology, Beijing Medical University, Beijing, China 2Institute of Human Living Sciences, Otsuma Women’s University, Tokyo, Japan ABSTRACT Data on the prevalence of the first ejaculating emission for 83,902 Chinese boys 9 through 18 years were collected using interviews. Median spermarcheal ages (MSAs) were calculated by using the status quo data and probit analysis. Subjects consisted of 61,812 Han boys from urban and rural areas in 29 provinces, and 22,090 minority boys from 17 minority ethnic groups. Median spermarcheal ages were 14.24 years for urban Han boys and 14.85 years for rural Han boys, and ranged from 13.46 to 16.32 years for the 17 minority ethnic groups. The differences in MSAs between urban and rural Han boys in each province were significant and the correlation ,0.83 ס between MSA of urban and rural boys in each province was high (r P < 0.001). For both urban and rural Han boys, there were significant geo- graphic variations. MSAs of boys living in north China were generally higher than those living in the south, while those living in the west were higher than those living in the east. Variation in MSA may be related to ecological con- ditions in the Chinese Han populations. The different estimates of spermar- cheal ages with two approaches, periodical urine sample analysis vs. inter- view, and their effect on estimating male puberty are discussed.
    [Show full text]
  • Figure 3-7. Exposure-Response Array of Female Reproductive Effects, Maternal Weight and Toxicity, Following Oral Exposure to DIBP
    EPA/635/R-14/333 Preliminary Materials www.epa.gov/iris Preliminary Materials for the Integrated Risk Information System (IRIS) Toxicological Review of Diisobutyl Phthalate (DIBP) (CASRN No. 84-69-5) September 2014 NOTICE This document is comprised of preliminary materials. This information is distributed solely for the purpose of pre-dissemination review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy. It is being circulated for review of its technical accuracy and science policy implications. National Center for Environmental Assessment Office of Research and Development U.S. Environmental Protection Agency Washington, DC Preliminary Materials for the IRIS Toxicological Review of Diisobutyl Phthalate DISCLAIMER This document is comprised of preliminary materials for review purposes only. This information is distributed solely for the purpose of pre-dissemination review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. This document is a draft for review purposes only and does not constitute Agency policy. ii DRAFT—DO NOT CITE OR QUOTE Preliminary Materials for the IRIS Toxicological Review of Diisobutyl Phthalate CONTENTS PREFACE .....................................................................................................................................................
    [Show full text]
  • The Teen Years Explained: a Guide to Healthy Adolescent Development
    T HE T EEN Y THE TEEN YEARS EARS EXPLAINED EXPLAINED A GUIDE TO THE TEEN YEARS EXPLAINED: HEALTHY A GUIDE TO HEALTHY ADOLESCENT DEVELOPMENT ADOLESCENT : By Clea McNeely, MA, DrPH and Jayne Blanchard ADOLESCENT DEVELOPMENT A GUIDE TO HEALTHY DEVELOPMENT The teen years are a time of opportunity, not turmoil. The Teen Years Explained: A Guide to Healthy Adolescent Development describes the normal physical, cognitive, emotional and social, sexual, identity formation, and spiritual changes that happen during adolescence and how adults can promote healthy development. Understanding these changes—developmentally, what is happening and why—can help both adults and teens enjoy the second decade of life. The Guide is an essential resource for all people who work with young people. © 2009 Center for Adolescent Health at Johns Hopkins Bloomberg School of Public Health All rights reserved. No part of this book may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in critical articles and reviews. Printed in the United States of America. Printed and distributed by the Center for Adolescent Health at the Johns Hopkins Bloomberg School of Public Health. Clea McNeely & Jayne Blanchard For additional information about the Guide and to order additional copies, please contact: Center for Adolescent Health Johns Hopkins Bloomberg School of Public Health 615 N. Wolfe St., E-4543 Baltimore, MD 21205 www.jhsph.edu/adolescenthealth 410-614-3953 ISBN 978-0-615-30246-1 Designed by Denise Dalton of Zota Creative Group Clea McNeely, MA, DrPH and Jayne Blanchard THE TEEN YEARS EXPLAINED A GUIDE TO HEALTHY ADOLESCENT DEVELOPMENT Clea McNeely, MA, DrPH and Jayne Blanchard THE TEEN YEARS EXPLAINED A GUIDE TO HEALTHY ADOLESCENT DEVELOPMENT By Clea McNeely, MA, DrPH Jayne Blanchard With a foreword by Nicole Yohalem Karen Pittman iv THE TEEN YEARS EXPLAINED CONTENTS About the Center for Adolescent Health ........................................
    [Show full text]